Palette Life Sciences

medical devices

About

Palette Life Sciences is a medical device and life sciences company based in Santa Barbara, California. Founded in 2018 in Solna, Sweden, the company focuses on developing advanced medical solutions in urology, urogynecology, colorectal conditions, radiotherapy, and interventional oncology. With around 155 employees, Palette Life Sciences generates an estimated annual revenue of $38.9 million. The company specializes in creating innovative treatments for uncommon or challenging conditions, offering products like Barrigel®, a spacer that reduces radiation exposure during prostate cancer therapy, and Deflux® and Solesta®, both NASHA-based tissue bulking agents for treating pediatric vesicoureteral reflux and fecal incontinence, respectively. Palette Life Sciences serves healthcare professionals, including urologists and oncologists, with a commitment to improving patient outcomes through minimally invasive treatment options. In 2023, the company was acquired by Teleflex to enhance its urology portfolio and leverage its unique technologies.

Technologies

Amazon CloudFront Salesforce CSC Corporate Domains Route 53 Outlook Pardot Microsoft Office 365 Amazon AWS Google Maps Google Tag Manager Nginx WordPress.org Mobile Friendly Google Maps (Non Paid Users) Remote Circle

Keywords

urogynecology disorders colorectal conditions radiotherapy interventional oncology procedures pediatric urology medical device life sciences prostate cancer oncology urology medical equipment manufacturing acquisition medical devices palliative care healthcare innovation teleflex pharmaceuticals medical technology surgery pain management injectable treatments biologics clinical solutions healthcare products patient care medical supply therapeutic solutions disease management surgical interventions safety regulations

Location

2A Fogdevreten, Gothenburg, Vaestra Goetaland County, Sweden, 171 65

Related Companies

Companies in the same industry